Recorded Chinese product: 注射用醋酸丙氨瑞林注射用醋酸丙氨瑞林
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司
主要成分Active Ingredients
- 丙氨瑞林Bingan Ruilin
药物知识说明
丙氨瑞林是一种在国家药监局注册认定的药品。标注生产企业为马鞍山丰原制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司、马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司、马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用醋酸丙氨瑞林) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 马鞍山丰原制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司, 马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司, 马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用醋酸丙氨瑞林Recorded Chinese product: 注射用醋酸丙氨瑞林
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 25ug25 μg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 马鞍山丰原制药有限公司Chinese legal name: 马鞍山丰原制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20041093
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20041093
Manufacturer
Chinese legal name: 马鞍山丰原制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20041093
生产企业
马鞍山丰原制药有限公司(国产)
适应症
治疗子宫内膜异位症、子宫肌瘤。
用法用量
1.皮下或肌肉注射，月经来潮的d1～d2开始治疗，150 μg/次，或遵医嘱。|2.制剂在临用前用2ml灭菌生理盐水溶解。|3.对子宫内膜异位症3～6月为一个疗程。
不良反应
可出现因低雌激素状态引起的症状，如潮热、盗汗、阴道干燥或情绪改变，个别患者出现皮疹，停药后即可消失。
禁忌
1.孕妇、哺乳期妇女及原因不明阴道出血者禁用。 |2.对GnRH或类似物过敏者禁用。
注意事项
1.撤药时除因子宫内膜异位症引起的不孕症患者可采用突然停药外，其余患者均需采用逐步撤药的方法。 |2.用药期间如出现淋漓出血，可咨询医生调整剂量至200g/d。 |3.疗程一般不超过6个月，以防发生骨质丢失。
贮藏
遮光，密封保存。
规格
25ug
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.